Navigation Links
Ohio State study shows 2 drugs help adolescents with ADHD, aggression
Date:12/20/2013

COLUMBUS, Ohio Prescribing both a stimulant and an antipsychotic drug to children with physical aggression and attention-deficit/hyperactivity disorder (ADHD), along with teaching parents to use behavior management techniques, reduces aggressive and serious behavioral problems in the children, according to a study conducted by researchers at The Ohio State University Wexner Medical Center.

The study was conducted in conjunction with the University of Pittsburgh, Stony Brook University in New York and Case Western Reserve University in Ohio. The findings published online this week ahead of publication in the January issue of the Journal of the American Academy of Child and Adolescent Psychiatry.

"Combination pharmacotherapy is becoming common in child and adolescent psychiatry, but there has been little research evaluating it," said first author Michael Aman, director of clinical trials at Ohio State's Nisonger Center and emeritus professor of psychology. "Our findings may be considered somewhat controversial because they appear to support the use of two drugs over one for treating children with aggression and disruptive behavior when things do not seem to be going well. Many practitioners have been taught to 'Keep things simple and safe' in their medical training. In general, this is good advice."

For the "Treatment of Severe Childhood Aggression (TOSCA) Study," 168 children ages 6 to 12 who had been diagnosed with ADHD and displayed significant physical aggression were divided into two groups. All study participants received a psychostimulant drug called OROS methylphenidate and their parents received behavioral parent training for nine weeks. The researchers called this treatment combination "basic" because both are evidence-based and have been shown to be helpful for improving both ADHD and aggression.

Researchers wanted to see if they could expand or augment this treatment by adding a second medication. If there was room for improvement at the end of the third week, a placebo was added for the "basic group," while the antipsychotic drug risperidone was added for participants in the "augmented group."

Compared to the "basic group," the "augmented group" who received the stimulant drug and parent training plus risperidone showed significant improvement (on average with moderately better behavior) on the Nisonger Child Behavior Rating Form (NCBRF) Disruptive-Total Scale, the NCBRF Social Competence subscale and the Reactive Aggression part of the Antisocial Behavior Scale.

While there is always some risk with the addition of a second drug to the treatment package, the two drugs seemed to neutralize some of each other's potential side effects. For instance, children in the augmented group did not seem to have as much trouble falling asleep, once the risperidone was added, Aman said.

"We conducted this study because we viewed the combination of ADHD and significant physical aggression especially the aggression as a serious situation," Aman said. "It is not uncommon to use more than one medicine for other serious situations, such as when treating cancer or epilepsy for instance. Although doctors have often used stimulants and antipsychotics together in recent years, we did not have good evidence until now that they would work more effectively when carefully staged and given together."


'/>"/>

Contact: Eileen Scahill
Eileen.Scahill@osumc.edu
614-293-3737
Ohio State University Wexner Medical Center
Source:Eurekalert  

Related medicine news :

1. Kids II® Expands Pink Power Mom™ Program to Five More States
2. The Association for Molecular Pathology releases position statement on LDTs
3. Cleveland Clinic receives grant to study role of DNA damage in treatment-resistant prostate cancer
4. Prosvent Emerges As Preferred Treatment For Enlarged Prostate
5. Marijuana consumption in Washington state is higher than previously estimated, study finds
6. The Florida State Hospital Association Becomes Supporting Organization of the Healthier Hospitals Initiative
7. Auburn Tigers BCS Championship Tickets Along with Florida State Seminoles BCS Championship Tickets Now Available at Discounted Prices from Ticket Down
8. Pain drugs used in prostate gland removal linked to cancer outcome, Mayo Clinic-led study finds
9. Do patients in a vegetative state recognize loved ones?
10. Cupertino Plumbing Offers Same Day State-of-the-Art Water Heater Installation
11. Center for Nano-Optics becomes top-level Georgia State University research center
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Ohio State study shows 2 drugs help adolescents with ADHD, aggression
(Date:5/6/2016)... ... May 06, 2016 , ... ... scheduled to provide a unique keynote address at the 2016 Learning Summit ... stories of five community college students. Their stories—of complicated family issues, financial difficulties, ...
(Date:5/6/2016)... ... 2016 , ... Innovations with Ed Begley Jr. announced today ... via Discovery Channel. Dates and show times TBA. , AsedaSciences® was established in ... innovative cellular analysis. In this segment, viewers will learn how AsedaSciences utilizes flow ...
(Date:5/6/2016)... ... 06, 2016 , ... From May 4 to 6, EarQ and ... opportunity to learn more about Signia’s technology and the successful business and marketing techniques ... priority to see practices succeed in this highly competitive industry,” said Ed Keller, president ...
(Date:5/6/2016)... ... May 06, 2016 , ... Expert mattress researchers and ... launching in September, 2014 Sleepopolis has resided at Sleepopolis-mattress-reviews.com . The move ... sheets, mattress toppers, bed frames, and more. , Founder and Editor-in-Chief Derek Hales ...
(Date:5/6/2016)... ... May 06, 2016 , ... ... provider of career-focused education and corporate training, and the National Military Family Association, ... announce Maritza Aquino as the second full-tuition scholarship recipient of 2016. , ...
Breaking Medicine News(10 mins):
(Date:5/3/2016)... CITY, Mo. , May 3, 2016 /PRNewswire/ ... Kansas Medical Center,s Institute for Advancing Medical Innovation ... and commercialize new drugs, diagnostics and medical devices. ... provides BioNovus Innovations with rights to license, develop ... "This partnership represents ...
(Date:5/3/2016)... Sino-German High-Tech Fund to further expand product development, strengthen its disease modeling capabilities and increase market presence. ... ... ... ... Sino-German High-Tech Fund ...
(Date:5/3/2016)... 3, 2016 ACME Markets, ... and Delaware County Councilman Dave White ... in all ACME pharmacies across ... Control and Prevention (CDC), naloxone has saved 26,463 lives nationwide over ... Delaware County were authorized to administer naloxone ...
Breaking Medicine Technology: